Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Gaus

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Pharmaceutical Development and Technology|June 2, 2005
Formation of oligonucleotide adducts in pharmaceutical formulationsAchim H Krotz, Hans Gaus, Gregory E Hardee
Biochemistry|March 29, 2018
Structural Determinants for the Interactions of Chemically Modified Nucleic Acids with the Stabilin-2 Clearance ReceptorHans Gaus, Colton M Miller, Punit P Seth, et al.
Genes & Development|May 17, 2012
Widespread recognition of 5' splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotidesXavier Roca, Martin Akerman, Hans Gaus, et al.
Oligonucleotides|December 2, 2010
In vitro metabolic stabilities and metabolism of 2'-O-(methoxyethyl) partially modified phosphorothioate antisense oligonucleotides in preincubated rat or human whole liver homogenatesMin-Son Baek, Rosie Z Yu, Hans Gaus, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2019
Metabolism and Disposition of Volanesorsen, a 2'-<i>O</i>-(2 methoxyethyl) Antisense Oligonucleotide, Across SpeciesNoah Post, Rosie Yu, Sarah Greenlee, et al.
Journal of the American Society for Mass Spectrometry|December 4, 2003
Alternative approaches to infrared multiphoton dissociation in an external ion reservoirSteven A Hofstadler, Jared J Drader, Hans Gaus, et al.
Nucleic Acids Research|July 13, 2004
Synthesis and characterization of oligonucleotides containing conformationally constrained bicyclo[3.1.0]hexane pseudosugar analogsMartin A Maier, Yongseok Choi, Hans Gaus, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2005
Trichloroacetaldehyde modified oligonucleotidesHans Gaus, Phil Olsen, Kent Van Sooy, et al.
Nucleic Acid Therapeutics|March 3, 2022
Assay, Purity, and Impurity Profile of Phosphorothioate Oligonucleotide Therapeutics by Ion Pair-HPLC-MSClaus Rentel, Hans Gaus, Kym Bradley, et al.
Journal of Medicinal Chemistry|March 3, 2006
Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modificationsPrasad Dande, Thazha P Prakash, Namir Sioufi, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Pharmaceutical Development and Technology|June 2, 2005
Formation of oligonucleotide adducts in pharmaceutical formulationsAchim H Krotz, Hans Gaus, Gregory E Hardee
Biochemistry|March 29, 2018
Structural Determinants for the Interactions of Chemically Modified Nucleic Acids with the Stabilin-2 Clearance ReceptorHans Gaus, Colton M Miller, Punit P Seth, et al.
Genes & Development|May 17, 2012
Widespread recognition of 5' splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotidesXavier Roca, Martin Akerman, Hans Gaus, et al.
Oligonucleotides|December 2, 2010
In vitro metabolic stabilities and metabolism of 2'-O-(methoxyethyl) partially modified phosphorothioate antisense oligonucleotides in preincubated rat or human whole liver homogenatesMin-Son Baek, Rosie Z Yu, Hans Gaus, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 28, 2019
Metabolism and Disposition of Volanesorsen, a 2'-<i>O</i>-(2 methoxyethyl) Antisense Oligonucleotide, Across SpeciesNoah Post, Rosie Yu, Sarah Greenlee, et al.
Journal of the American Society for Mass Spectrometry|December 4, 2003
Alternative approaches to infrared multiphoton dissociation in an external ion reservoirSteven A Hofstadler, Jared J Drader, Hans Gaus, et al.
Nucleic Acids Research|July 13, 2004
Synthesis and characterization of oligonucleotides containing conformationally constrained bicyclo[3.1.0]hexane pseudosugar analogsMartin A Maier, Yongseok Choi, Hans Gaus, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2005
Trichloroacetaldehyde modified oligonucleotidesHans Gaus, Phil Olsen, Kent Van Sooy, et al.
Nucleic Acid Therapeutics|March 3, 2022
Assay, Purity, and Impurity Profile of Phosphorothioate Oligonucleotide Therapeutics by Ion Pair-HPLC-MSClaus Rentel, Hans Gaus, Kym Bradley, et al.
Journal of Medicinal Chemistry|March 3, 2006
Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modificationsPrasad Dande, Thazha P Prakash, Namir Sioufi, et al.
Pageof 4